Larson Financial Group’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
Other funds holding SLS
Larson Financial Group's SLS Position: Q3 2026 in Review
Larson Financial Group increased its SELLAS Life Sciences (SLS) stake by 3.4% in Q3 2026, buying an estimated $2.96K and bringing the position to 7,246 shares worth $89.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1293.
Larson Financial Group first reported a position in SLS in Q4 2025 and has held it in 4 quarters since. The position peaked at $103K in Q2 2026. 218 funds tracked by Wall St. Rank hold SLS as of Q3 2026.
- Larson Financial Group held 7,246 shares of SELLAS Life Sciences worth $89.2K as of Q3 2026.
- Larson Financial Group bought 236 SELLAS Life Sciences shares in Q3 2026, an estimated $2.96K.
- SELLAS Life Sciences made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #1293 holding.
- Larson Financial Group first reported a position in SELLAS Life Sciences in Q4 2025 and has held it in 4 quarters since.
- Larson Financial Group's SELLAS Life Sciences position peaked at $103K in Q2 2026.
- 218 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.